According to Cytosorbents's latest financial reports the company's current EPS (TTM) is -$0.97. In 2022 the company made an earnings per share (EPS) of -$1.21 a decrease over its 2021 EPS that were of -$0.92.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.91 | -24.94% |
2022 | -$1.21 | 31.58% |
2021 | -$0.92 | 171.43% |
2020 | -$0.34 | -64.41% |
2019 | -$0.95 | 5.36% |
2018 | -$0.90 | 86.67% |
2017 | -$0.48 | -36.17% |
2016 | -$0.76 | 27.03% |
2015 | -$0.60 | -67.55% |
2014 | -$1.84 | 14.02% |
2013 | -$1.62 | 33.33% |
2012 | -$1.21 | -25% |
2011 | -$1.62 | -20% |
2010 | -$2.02 | -37.5% |
2009 | -$3.23 | -50% |
2008 | -$6.46 | -11.11% |
2007 | -$7.27 | -80.88% |
2006 | -$38.01 |